Presentation is loading. Please wait.

Presentation is loading. Please wait.

What’s New With Attention-Deficit/Hyperactivity Disorder In Adults?

Similar presentations


Presentation on theme: "What’s New With Attention-Deficit/Hyperactivity Disorder In Adults?"— Presentation transcript:

1 What’s New With Attention-Deficit/Hyperactivity Disorder In Adults?
Kevin T. Blake, Ph.D., P.L.C. What’s New With Attention-Deficit/Hyperactivity Disorder In Adults? Kevin T. Blake, Ph.D., P.L.C. Tucson, AZ Cross Country Education Brentwood, TN Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

2 ADHD is NOT new! Crichton wrote about what we call ADHD in 1798!
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved ADHD is NOT new! Crichton wrote about what we call ADHD in 1798! Crichton, A. (2008). An inquiry into the nature and origin of mental derangement: On attention and its diseases. Journal of Attention Disorders, 12, (Original work published 1798). Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

3 Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 ADHD is NOT new! In 1770 Melchor Adam Weikart, of Germany described syndrome very similar to AD/HD. He recommended horseback riding and exercise as treatment. He corresponded with Alexander Crichton. Barkley, R.A. (2012). ADHD: Cutting Edge Understanding and Management. Seminar sponsored by J&K Seminars, L.L.C., 1861 Wickersham Lane, Lancaster, PA , p.1. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

4 The Four Types of AD/HD in DSM-IV, TR
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 The Four Types of AD/HD in DSM-IV, TR Attention-Deficit/Hyperactivity Disorder, Combined Type Attention-Deficit/Hyperactivity Disorder, Predominately Inattentive Type Attention-Deficit/Hyperactivity Disorder, Predominately Hyperactive/Impulsive Type Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

5 DSM-IV, TR ADHD Subtypes (Continued)
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 DSM-IV, TR ADHD Subtypes (Continued) Attention-Deficit/Hyperactivity Disorder, Not Otherwise Specified American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition-Text Revision. Washington, DC: American Psychiatric Association. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

6 Summary of Barkley’s Theory Of AD/HD, Combined Type
Kevin T. Blake, Ph.D., P.L.C. Summary of Barkley’s Theory Of AD/HD, Combined Type All Rights Reserved Step 1: Response Delay Step 2: Prolongation Step 3: Rule Governed Behavior Step 4: Dismemberment of the Environment Barkley, R.A. (1997). ADHD and the Nature of Self-Control. New York, NY: Guilford. Barkley, R.A. (2006). Attention-Deficit Hyperactivity Disorder, Third Edition. New York, NY: Guilford. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

7 Summary of Tom Brown’s Theory Of AD/HD, Combined Type
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Summary of Tom Brown’s Theory Of AD/HD, Combined Type Brown believes the following are the areas of difficulty in the Combined Type of AD/HD: 1. Difficulty organizing and activating for work 2. Problems sustaining attention and concentration 3. Problems sustaining energy and effort Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

8 Brown Brown’s Theory (Continued)
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Brown Brown’s Theory (Continued) 4. Problems managing affective interference 5. Problems utilizing working memory and accessing recall 6. Problems being able to predict the reaction of others due to their behavior (Lack of Forethought) Brown, T.E. (1995). Differential Diagnosis of ADD Versus ADHD in adults. In K.G. Nadeau (Ed.), Attention-Deficit Disorder in Adults. New York, NY: Bruner/Mazel, Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

9 Executive Functions and AD/HD
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Executive Functions and AD/HD It appears the problems those with AD/HD have with academic achievement and social communication and behavior are related to EF (Executive Functions) difficulties. This does not appear to be the case in those with ODD and/or CD without AD/HD. Clark, C., Prior, M. and Kinsella, G. (2002). The Relationship Between Executive Function Abilities, Adaptive Behavior, and Academic Achievement in Children with Externalizing Behavior Problems, Journal of Child Psychology and Psychiatry, 43, p From: (June, 2003). Executive Function and Communication Difficulties May Contribute to Adaptive Behavior Problems. ADHD Report, p Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

10 Note! 55% of those with AD/HD have comorbid Oppositional Disorder
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 Note! 55% of those with AD/HD have comorbid Oppositional Disorder 45% of those with AD/HD have comorbid Conduct Disorder Barkley, R.A. (2012). ADHD: Cutting Edge Understanding and Management. Seminar sponsored by J&K Seminars, L.L.C., 1861 Wickersham Lane, Lancaster, PA , p. 14. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

11 Executive Memory Function Problems
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Executive Memory Function Problems Working Memory: “…denotes a person’s information-processing capacity” (p. 4-5) Is the “memory buffer in the brain.” It allows for “theory of mind.” “Remembering so as to do.”(non-informational) Wechsler Adult Intelligence Scale- Third Edition, Wechsler Memory Scale-Third Edition (1997). Technical Manual. San Antonio, TX : Psychological Corporation. Brown, T. E. (October 11, 2001). Assessment and Treatment of Complicated ADHD Across the Lifespan. Seminar Presented at the Arizona Association of School Psychologists 33rd Annual Conference, Mesa, AZ. Frith, C. D. and Frith, U. (1999). Intersecting Minds-A Biological Basis. Science, 286, pp Barkley, R.A. (2008). Advances in ADHD: Theory, Diagnosis and Management. J & K Seminars, L.L.C., 1861 Wichersham Lane, Lancaster, PA 17603; ; Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

12 Working Memory and AD/HD
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Working Memory and AD/HD “AD/HD kids are not ‘clueless’. They’re ‘cueless’.” Goldstein, S. (November 20, 1998). Pathways to Success:Evening the Odds in the Treatment of Attention-Deficit Hyperactivity Disorder. Seminar presented in Tucson, AZ. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

13 Executive Function Defined
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 Executive Function Defined “The use of self-directed actions so as to choose goals and to select, enact, and sustain actions across time toward those goals usually in the context of others often relying on social and cultural means for the maximization of one’s long-term welfare as a person defines that to be” (p. 171). Barkley, R.A. (2012). Executive Functions: What They Are, How they Work, and Why They Evolved. New York, NY: Guilford. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

14 Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 AD/HD in a Nutshell “ADHD is currently understood as a neurodevelopmental syndrome with symptoms that are highly heritable and neurobiological in origin. Pharmacotherapy stands alone as the single most efficacious treatment for ADHD for individuals of all ages. Medications, psychostimulants in particular are effective in reducing the core symptoms of inattention, hyperactivity and impulsivity.” (p. 3) Ramsay, R. (2010). Nonmedication treatments for adult ADHD. Washington, DC: American Psychological Association Press, p. 3. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

15 Barkley on Hyperactive/Impulsive ADHD
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 Barkley on Hyperactive/Impulsive ADHD “The HI-Type (Hyperactive/Impulsive Type ADHD, sic.) is apparently a milder or earlier stage of the C-Type (Combined Type ADHD, sic.), most commonly Identified in preschool age children.” (p. 1) Barkley, R.A. (October, 2011). Sluggish Cognitive Tempo Is a Distinct Disorder from ADHD in Adults. The ADHD Report, 19(5), 1-6. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

16 Changes in AD/HD Subtypes Over Time
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 Changes in AD/HD Subtypes Over Time “We found two hyperactivity-impulsivity trajectories (low, high/decreasing) and two inattention trajectories (low, high/increasing). Twin modeling revealed a substantial genetic component underlying both the hyperactivity-impulsivity and the inattention trajectory. Joint trajectory analyses identified four groups of adolescents with distinct developmental patterns of hyperactivity-impulsivity and inattention: a low/low group, a primarily hyperactive, a primarily inattentive and a combined (high/high) trajectory type…” Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

17 Changes in AD/HD Subtypes Over Time (Continued)
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 Changes in AD/HD Subtypes Over Time (Continued) “… These trajectory combinations showed discriminant relations to adjustment problems in early adulthood. The hyperactive, inattentive and combined trajectory subtypes were associated with higher rates of family risk environments compared to the low/low group” (p. 254). Larsson, H., Dilshad, R., Lichtenstein, P., and Barker, E.D. (September 2011). Developmental trajectories of DSM-IV symptoms of attention-deficit/hyperactivity disorder: genetic effects, family risk and associated psychopathology. Journal of Child Psychology and Psychiatry, 52(9), Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

18 Kevin T. Blake, Ph.D., P.L.C. Attention-Deficit/Hyperactivity Disorder, Predominately Hyperactive-Impulsive Type All Rights Reserved Tzelepis stated she has only seen Combined Type adults in her work and doubts the Predominately Hyperactive-Impulsive Type exists in adults. Tzelepis, A. and Mapou, R. (1997, May). Assessment. Paper presented at the Pre-Conference Professional ADD Institute of the 3rd Annual National ADDA Adult ADD Conference, St. Louis, MO. Barkley, Murphy and Fischer make similar observations. Barkley, R.A., Murphy, K.R., & Fischer, M. (2008). ADHD in Adults: What The Science Says. New York, NY: Guilford, p Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

19 Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Brown Brown called those who met DSM criteria for Hyperactive-Impulsive Type or Combined Type in Childhood, but only met criteria for Inattentive Type in Adulthood, ‘CROSSOVERS’. Brown, T.E. (1995). Differential Diagnosis of ADD Versus ADHD in Adults. In K.G. Nadeau (Ed.), A Comprehensive Guide to Attention-Deficit Disorder in Adults. New York: Bruner/Mazel, pp Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

20 Crossovers? What Longitudinal Studies How
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Crossovers? What Longitudinal Studies How Barkley, R.A., Murphy, K.R., & Fischer, M. (2008). ADHD in Adults: What The Science Says. New York, NY: Guilford. Weiss, G., & Hechtman, L. (1993). Hyperactive Children Grown Up. New York, NY: Guilford. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

21 Crossovers (Continued)
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Crossovers (Continued) Barkley wrote when the Combined Type changes to the Inattentive Type by adolescence or adulthood then the person should be thought of as having the Combined Type. Barkley, R.A. (2002). ADHD and Oppositional Defiant Children. Seminar presented, February 19-20, Phoenix, AZ., The Institute for Continuing Education, Fairhope, AL. Barkley, R.A. (2006). Attention-Deficit Hyperactivity Disorder, Third Edition. New York, NY: Guilford. Barkley, R.A., Murphy, K.R., & Fischer, M. (2008). ADHD in Adults: What The Science Says. New York, NY: Guilford, p Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

22 What does “Neurobiological” mean?
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved What does “Neurobiological” mean? Stephen Pinker – “The Blank Slate: The Modern Denial of Human Nature” or better stated, “the Lie of the Blank Slate.” Pinker, S. (2002). The Blank Slate: The Modern Denial of Human Nature. New York, NY: Viking. AD/HD is not caused by child rearing practices or environmental experience. Barkley, R. A. (2002A-Tape 1). ADHD Symposium: Nature, Diagnosis and Assessment-Nature and Comorbidity and Developmental Course of ADHD. University of Massachusetts, January, Westborough, MA: Stonebridge Seminars. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

23 AD/HD, Combined Type Genes
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved AD/HD, Combined Type Genes DRD4 – 7 + Repeat DAT1 – 480 bp DBH – Taql (A2 allele) DRD2 SNAP25 MAO-A 13 other possible genes Barkley, R.A. (2008). ADHD: Advances in, Nature, Diagnosis, and Etiology. Handout for seminar: Advances in ADHD: Theory, Diagnosis and Management. J & K Seminars, L.L.C., 1861 Wichersham Lane, Lancaster, PA 17603; ; p. 9 (Handout). Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

24 The Neurology of the Combined Type of AD/HD
Kevin T. Blake, Ph.D., P.L.C. The Neurology of the Combined Type of AD/HD All Rights Reserved Barkley stated there are three areas of the brain that are significantly different in those who are AD/HD: The Orbital Prefrontal Cortex-Primarily the Right Side The Cerebellar Vermis-Primarily the Right Side The Basal Ganglia-Striatum and Globus Pallidus Barkley, R.A. (2002B). ADHD and Oppositional Defiant Children. Seminar presented February 19-20, Phoenix, AZ. Barkley, R.A. (2006). Attention-Deficit Hyperactivity Disorder. New York, NY: Guilford, Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

25 What The Cerebellum Does
Kevin T. Blake, Ph.D., P.L.C. What The Cerebellum Does All Rights Reserved Allen indicated neuroimaging studies show the Cerebellum is involved in the following functions: Attention Forms of Learning Memory tasks Conditional anxiety Complex reasoning and problem solving Sensory and Motor Tasks Allen, G. (March 11, 1998). Functional Diversity of the Cerebellum. Paper presented at the New Angles on Motor and Sensory Coordination in Learning Disabilities Topical Medical Workshop; Learning Disabilities Association, International Conference, Washington, DC; Infomedia, tape R130-W1A, Garden Grove, CA. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

26 The Cerebellum & Social Interaction
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved The Cerebellum & Social Interaction “The Cerebellum has only recently been implicated in the normal functioning of social behavior…new research has shown that the cerebellum is important as a mediator in cognition. To perceive an object or event, we must pull together the various sensory qualities and any relevant memories or thoughts in a carefully timed way…the cerebellum assists in delaying or accelerating these associations,and regulates attentional states…” Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

27 The Cerebellum & Social Interaction (Continued)
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved The Cerebellum & Social Interaction (Continued) “Coordinating associations and attention is essential to entering into a relationship with another human being. Communication, conversation, and graceful social interaction all depend on being able to pay attention to another person and to one’s own internal states and to alternate easily back and forth between them.” (p.305) Ratey, J.J. (2001). A User’s Guide to the Brain: Perception, Attention, and the Four Theaters of the Brain. New York, NY: Vintage. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

28 European Perspectives of AD/HD
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved European Perspectives of AD/HD Disorder of Attention, Motor Control and Perception (DAMP): Swedish researchers have been doing longitudinal research since 1977 with a group of children with AD/HD and Developmental Coordination Disorder which they view as one disorder called DAMP. At age 22 30% of the children still met criteria for AD/HD and DCD. Gillberg, C. (2001). ADHD with Comorbid Developmental Coordination Disorder: Long-Term Outcome in a Community Sample, ADHD Report, 9 (2), pp. 5-9 Gillberg, C. and Kadesjo, B. (2000). Attention-Deficit/Hyperactivity Disorder and Developmental Coordination Disorder. In T.E. Brown (Ed.), Attention-Deficit Disorders and Comorbidities in Children, Adolescents and Adults. Washington, DC: American Psychiatric Press, pp Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

29 What does “Neurobiological” mean?
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved What does “Neurobiological” mean? 65 to 75% of the cases of Combined Type ADHD are caused by genetic anomalies. These people with ADHD are said to have “developmental ADHD.” Barkley, R.A. (2008). Advances in ADHD: Theory, Diagnosis and Management. J & K Seminars, L.L.C., 1861 Wichersham Lane, Lancaster, PA 17603; ; 80 to 85% of the variance of those with developmental ADHD is genetic. I.Q. is 60 to 65% genetic. Barkley, R. A. (2002A-Tape 1). ADHD Symposium: Nature, Diagnosis and Assessment-Nature and Comorbidity and Developmental Course of ADHD. University of Massachusetts, January, Westborough, MA: Stonebridge Seminars. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

30 Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved “Acquired ADHD” 25 to 35% of cases of ADHD are acquired/caused by brain trauma 15 to 25% of cases of ADHD are acquired/caused by pre-natal and perinatal brain injuries: Maternal smoking/drinking, premature birth, etc. 3 to 7% of cases of ADHD are acquired/caused by post- natal brain injuries: head trauma, infections, tumors, lead poisoning, PANDAS, etc. Barkley, R.A. (2008). Advances in ADHD: Theory, Diagnosis and Management. J & K Seminars, L.L.C., 1861 Wichersham Lane, Lancaster, PA 17603; ; Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

31 Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved “Acquired” AD/HD Nigg recently found while doing NIH funded research that, “Blood lead levels were significantly higher in children with ADHD, combined type, but this was not the case in children who had ADHD, predominately inattentive type. Nigg and his group believe that high lead levels in the blood might play a role in the hyperactivity component of ADHD, but not the inattentive component of it.” (p. 1 of 2). Arechart-Treichel, J. (November 2, 2007). Lead in Children’s Blood May Contribute to ADHD’s Hyperactivity Component. Psychiatric News, 42 (21), p. 20. From: p. 1 of 2. Nigg, J.T., Knottnerus, G.M., Martel, M.M., Nikolas, M., Cavanagh, K., Karmaus,W. and Rappley, M.D. (2008). High Blood Lead Levels Associated with Clinically Diagnosed Attention-Deficit/Hyperactibity Disorder and Mediated by Weak Cognitive Control. Biological Psychiatry, 63 (3), pp Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

32 “Acquired” ADHD Most of those with “acquired” ADHD are males.
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved “Acquired” ADHD Most of those with “acquired” ADHD are males. The male brain is more prone to injury and genetic difficulties than the female brain. Barkley, R.A. (2008). Advances in ADHD: Theory, Diagnosis and Management. J & K Seminars, L.L.C., 1861 Wichersham Lane, Lancaster, PA 17603; ; Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

33 What does “Neurobiological” mean?
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved What does “Neurobiological” mean? Damage to different neural networks may cause AD/HD symptoms. Differences in Brain Development may cause them, too (more common). AD/HD, “…is a condition of the brain produced by genes.” ADHD has multiple causes Swanson, J. and Castellanos, X. (1998). Biological Basis of Attention Deficit Hyperactivity Disorder: Neuroanatomy, Genetics, and Pathophysiology. Available from- Biederman, J. (October 27, 2006). Advances in The Neurobiology of AD/HD. Paper presented at the 18th Annual CHADD International Conference, Chicago, IL. Barkley, R.A. (2008). Advances in ADHD: Theory, Diagnosis and Management. J & K Seminars, L.L.C., 1861 Wichersham Lane, Lancaster, PA 17603; ; Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

34 Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved ADHD and Employment 80% of AD/HD children suffer social rejection by second grade. Impulsivity? Barkley, R.A. (2008). Advances in ADHD: Theory, Diagnosis and Management. J & K Seminars, L.L.C., 1861 Wichersham Lane, Lancaster, PA 17603; ; Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

35 Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved ADHD and Employment Difficulty with others is one of the main reasons AD/HD adults loose their jobs. .. Ratey, N. and Griffith-Haynie, M. (1998). Coaching to Improve Workplace Performance. Paper presented at the Fourth Annual ADDA Adult ADD Conference, March 26-28, Washington, DC. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

36 AD/HD and Employment One-half of AD/HD adults are unemployed
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved AD/HD and Employment One-half of AD/HD adults are unemployed Biederman, J. (October 27, 2006). Advances in The Neurobiology of AD/HD. Paper presented at the 18th Annual CHADD International Conference, Chicago, IL. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

37 Employment & ADHD ADHD workers have significantly lower salaries.
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Employment & ADHD ADHD workers have significantly lower salaries. They are absent from the job more and significantly more underproductive than non-ADHD workers. They have more on the job accidents. On average ADHD costs the household $10,000 per year of income. Ramsay, R. J. (2010). Non-Medication Treatments for Adult ADHD. Washington, DC: American Psychological Association, p. 79. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

38 Mirror Neurons & Executive Functions
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 Mirror Neurons & Executive Functions “Studies show that the capacity to imitate the actions of others is now virtually an instinct at the level of neuronal functioning. The PFC (Prefrontal Cortex, sic) responds to viewing others’ actions by activating the same sensory-motor regions of the brain as the acting person is using to create the behavior. The mirror-neuronal system has been linked to theory of mind and to empathy, among other human attributes related to EF (Executive Functions, sic.)” (p. 117). Barkley, R.A. (2012). Executive Functions: What They Are, How they Work, and Why They Evolved. New York, NY: Guilford. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

39 Mirror Neurons How does the following relate to AD/HD?:
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Mirror Neurons How does the following relate to AD/HD?: “If the mirror neuron system serves as a bridge in this process, then in addition to providing an understanding of other peoples intentions, it may have evolved to become an important component in the human capacity for observation-based learning and sophisticated cognitive skills.” (p. 61) Rizzolatti, G., Fogassi, L. and Gallese, V. (November, 2006). Mirrors in The Mind. Scientific American, 296 (5), pp Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

40 Mirror Neurons How does this relate to ADHD?
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Mirror Neurons How does this relate to ADHD? Barkley (2008) said that those with Combined Type AD/HD and comorbid Alexithymia typically have intact mirror neurons, they just do not use their mirror neurons due to their frontal lobe difficulties. Barkley, R.A. (2008). Advances in ADHD: Theory, Diagnosis and Management. J & K Seminars, L.L.C., 1861 Wichersham Lane, Lancaster, PA 17603; ; Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

41 Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Memes & AD/HD Barkley spoke of how many of those with AD/HD have difficulty with the internalization of speech, and how this in turn can make AD/HD people vulnerable to others “stealing their ideas.” In addition, their impulsivity may cause problems with vicarious learning. Those with AD/HD may have trouble “stealing” the ideas of others. Barkley, R.A. (February 19-20, 2002). ADHD and Oppositional Defiant Children. Seminar presented in Phoenix, Arizona. Barkley, R. A. (2006). Attention-Deficit Hyperactivity Disorder, Third Edition. New York, NY: Guilford, p. 310 Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

42 Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Dyssemia Those with AD/HD have trouble with vicarious learning and would be expected to have trouble learning non-verbal social interaction which is not directly taught. Their impulsivity would make it difficult for them to attend to the non-verbal cues of others, too. Barkley, R.A. (February 19-20, 2002). ADHD and Oppositional Defiant Children. Seminar presented in Phoenix, Arizona. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

43 Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Mimicry “Our talent for mimicry may serve an important purpose. Some studies imply that spontaneous imitation acts as a ‘social glue’ promoting feelings of friendliness and a sense of togetherness.” (p. 55) If you mimic someone you are seen as friendly; if not, you are seen as less friendly. You must inhibit imitation to coordinate interactions with others. Those with AD/HD have trouble with this. Sebanz, N. (December 2006/January 2007). It Takes 2 To…Scientific American: Mind. 17 (6), pp Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

44 Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Dyssemia In DSM-5 AD/HD can be comorbid with Autism Spectrum Disorders. Brown, T.E. (2000). Attention-Deficit Disorders and Comorbidities in Children, Adolescents and Adults. Washington, D C: American Psychiatric Press. Barkley, R.A. (2008). Advances in ADHD: Theory, Diagnosis and Management. J & K Seminars, L.L.C., 1861 Wichersham Lane, Lancaster, PA 17603; ; Author (2010). Asperger Disorder. Washington, DC: American Psychiatric Association; Author (2010). Autistic Disorder. Washington, DC: American Psychiatric Association; Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

45 AD/HD and Autism Spectrum Disorders (ASD)
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 AD/HD and Autism Spectrum Disorders (ASD) 26% of children with PDD-NOS, or ASD have comorbid Combined Type AD/HD 33% of children with PDD-NOS, or ASD have Comorbid Inattentive AD/HD 59% of Children with PDD-NOS, or ASD have some type of AD/HD Goldstein, S. and Naglieri, J.A. (August, 2011). Neurocognitive and Behavioral Characteristics of children with ADHD and Autism: New Data and Strategies. The ADHD Report, 19(4), 10-12,16. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

46 Barkley’s 30% Rule for Combined AD/HD
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Barkley’s 30% Rule for Combined AD/HD People with Combined Type AD/HD tend to be on average 30% less mature in controlling their hyperactivity, impulsivity, and inattentiveness than their non-disabled age peers. Barkley, R.A. (1998). ADHD in Children, Adolescents and Adults: Diagnosis, Assessment and Treatment. New England Educational Institute, Cape Cod Symposium (August), Pittsfield, MA. Barkley, R.A. (2008). Advances in ADHD: Theory, Diagnosis and Management. J & K Seminars, L.L.C., 1861 Wichersham Lane, Lancaster, PA 17603; ; Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

47 Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Warning for Driver’s Education Instructors with AD/HD Combined Types Students! The average 16 year old with Combined Type AD/HD functions like an 11 year old when it comes to controlling their hyperactivity, impulsivity and inattentiveness. How many of you would want an 11 year old behind the wheel of a car? Barkley, R.A., Murphy, K.R. and Fischer, M. (2008). ADHD In Adults: What The Science Says. New York, NY: Guilford. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

48 Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Warning for Driver’s Education Instructors with AD/HD Combined Type Students! AD/HD teens are more likely to have driven a car illegally before they have their drivers license. They are less likely to be employing good driving habits. They will incur many more traffic citations, especially for speeding. They are four times more likely to be in an accident. They will have even more problems if they have Oppositional Defiant Disorder and/or Conduct Disorder with their AD/HD. Unmedicated people with AD/HD who are sober handle a car as well as a person who is not AD/HD who is legally drunk! Barkley, R.A. (2006). Attention Deficit Hyperactivity Disorder, Third Edition. New York, NY, Guilford. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

49 Warning: Driving and AD/HD
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Warning: Driving and AD/HD “Fortunately, the driving performance of adults with ADHD has been shown to improve with medication management, at least those aspects of poor driving likely to derive from ADHD itself.” (p. 376) Barkley, R.A., Murphy, K.R. and Fischer, M. (2008). ADHD In Adults: What The Science Says. New York, NY: Guilford. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

50 Warning for Health Class Instructors!
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Warning for Health Class Instructors! People with AD/HD may have a significantly reduced life expectancy due to an impulsive lack of concern for health related issues, exercise, diet, drugs, etc. Barkley, R.A. (1998). Attention-Deficit Hyperactivity Disorder, Second Edition. New York, NY: Guilford. Barkley, R.A. (2006). Attention-Deficit Hyperactivity Disorder, Third Edition. New York, NY: Guilford, p. 165. Spend significantly more time with them emphasizing the importance of good health and developing ways to ensure they follow through with annual check-ups, etc. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

51 Sleep Disorders and AD/HD
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 Sleep Disorders and AD/HD Children with AD/HD: Up to 39% sleep walk 56% have trouble going to sleep Have fewer sleep hours than non-AD/HD children Have more movement during sleep Have more periods of sleepiness during the day Barkley, R.A. (2006). Attention-Deficit/Hyperactivity Disorder, Third Edition. New York, NY: Guilford. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

52 Sleep Disorders and AD/HD
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 Sleep Disorders and AD/HD 30 to 56% of those with AD/HD have sleep disorders Stimulant medications can lengthen sleep onset Sleep problems may exacerbate academic/work problems, but if academic/work problems not caused by Sleep problem, better sleep may not translate to fewer waking problems. Barkley, R.A. (2012). ADHD: Cutting Edge Understanding and Management. Seminar sponsored by J&K Seminars, L.L.C., 1861 Wickersham Lane, Lancaster, PA , p. 28. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

53 Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Social Disorders AD/HD Combined Type men married less, reported interpersonal and sexual problems, had general difficulties with socialization, difficulties with heterosocial responses and problems with assertiveness (Weiss and Hechtman, 1993) Those with AD/HD often have problems with emotional regulation. This causes problems, too. Weiss, G. and Hechtman, L.T. (1993). Hyperactive Children Grown Up (Second Edition). New York, NY:Guilford. Canu, W.H. and Carlson, C.L. (April, 2004). ADHD and Social Adaptation From Childhood to Adulthood. ADHD Report, 12 (2), pp. 1-6. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

54 Decoding Skill and Facial Expression
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Decoding Skill and Facial Expression Brown (2001) indicated AD/HD children are less accurate in facial expression identification than their non-AD/HD peers. Brown, T. E. (2001). Social Ineptness & “Emotional Intelligence” in ADHD. Paper presented at the 13th Annual Children and Adults With Attention Deficit Disorders International Conference, October , Anaheim , CA. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

55 Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Problems Making the Appropriate Facial Expression to Match How One Feels and What is Appropriate to The Situation Unmedicated AD/HD, Combined Type people have difficulty making facial expressions to match how they feel. They tend to “over-emote” their facial expressions. (Kuehle, et.al., 2002). Kuehle, H.J., Hoch, C. and Jansen, F. (2002). Video Assisted Observation of Visual Attention, Facial Expression of the Individual, Stimulant Dosage and Motor Behavior for the Diagnosis and for the Determination in Children with AD/HD. Obtained from: Kuehle, H. (October 17, 2002). Video Assisted Observation of Visual Attention and Motor Behavior for the Diagnosis and Determination of the Individual Stimulant Dosage in Children with AD/HD. Research Poster Session, 14th Annual CHADD International Conference, Miami Beach, FL. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

56 Facial Expression and Social Ability
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Facial Expression and Social Ability Regarding facial expressions in children and adults with AD/HD Kuhle, Hoch, Rautzenberg and Jansen (2001) concluded, “Altogether, … the facial expressions, are uncontrolled and jerky and are often wrongly dimensioned in time and space.” (p. 6) Kuhle, H.J., Hoch, C., Rautzenberg, P. and Jansen, F. (2001). Short-Term Video-Based Observation of Behavior with Special Reference to Eye-Contact, Facial Expression and Motor Activity in Diagnosis and Therapy of Attention Deficiency/ Hyperactivity Syndrome (ADHS). (First Published in): Praxis der Kinderpsychologie und Kinderpsychiatrie 50: Obtained from: Kuehle, H. (October 17, 2002). Video Assissted Observation of Visual Attention and Motor Behavior for the Diagnosis and Determination of the Individual Stimulant Dosage in Children with AD/HD. Research Poster Session, 14th Annual CHADD International Conference, Miami Beach, FL. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

57 Facial Expressions and AD/HD
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Facial Expressions and AD/HD AD/HD childrens’ eyes drift away from those they are in conversation with. This usually interrupts the flow and their comprehension of the conversation. Often parents feel rejected by AD/HD children when they do this. Kuehle, H.J., Hoch, C and Jansen, F. (2002). Video Assisted Observation of Visual Attention, Facial Expression of the Individual Stimulant Dosage and Motor Behavior for the Diagnosis and for the Determination in Children with AD/HD. Obtained from: Kuehle, H. (October 17, 2002). Video Assissted Observation of Visual Attention and Motor Behavior for the Diagnosis and Determination of the Individual Stimulant Dosage in Children with AD/HD. Research Poster Session, 14th Annual CHADD International Conference, Miami Beach, FL. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

58 Facial Expressions and AD/HD
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Facial Expressions and AD/HD AD/HD children smile abruptly. There is little or no transition between emotional states. Sometimes their facial expression bleeds over into the next emotional state. Expression of emotion often appears exaggerated. The quality of expression can be limited due to this. Even body movements are jerky and uncontrolled. Kuehle, H.J., Hoch, C. and Jansen, F. (2002). Video Assisted Observation of Visual Attention, Facial Expression of the Individual Stimulant Dosage and Motor Behavior for the Diagnosis and for the Determination in Children with AD/HD. Obtained from: Kuehle, H. (October 17, 2002). Video Assisted Observation of Visual Attention and Motor Behavior for the Diagnosis and Determination of the Individual Stimulant Dosage in Children with AD/HD. Research Poster Session, 14th Annual CHADD International Conference, Miami Beach, FL. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

59 Possible Treatment of Problems with Facial Expression and AD/HD
Kevin T. Blake, Ph.D., P.L.C. Possible Treatment of Problems with Facial Expression and AD/HD All Rights Reserved Optimal dosing of a stimulant medication causes a significant reduction in visual attention loss. Facial expressions will become smooth and variable. Too high a dose can cause a return of the symptoms. Can properly ID 80% of the AD/HD children with video procedure. Kuhle, H.J., Hoch, C., Rautzenberg, P. and Jansen, F. (2001). Short-Term Video-Based Observation of Behavior with Special Reference to Eye-Contact, Facial Expression and Motor Activity in Diagnosis and Therapy of Attention Deficiency/ Hyperactivity Syndrome (ADHS). (First Published in): Praxis der Kinderpsychologie und Kinderpsychiatrie 50: Obtained from: Kuehle, H. (October 17, 2002). Video Assissted Observation of Visual Attention and Motor Behavior for the Diagnosis and Determination of the Individual Stimulant Dosage in Children with AD/HD. Research Poster Session, 14th Annual CHADD International Conference, Miami Beach, FL. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

60 ADHD & Amygdala/Frontal Lobe
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 ADHD & Amygdala/Frontal Lobe “Our findings demonstrate that in adolescents with ADHD, a neural substrate of fear processing is atypical, as is the connectivity between the amygdala and LPFC (lateral prefrontal cortex, sic.). These findings suggest possible neural substrates for the emotional reactivity that is often present in youths with ADHD, and provide putative neural targets for the development of novel therapeutic interventions for this condition”. (p. 828) Posner, J. Nagel, B.J., Maia, T.V., Oh, M., Wang, Z., and Peterson, B.S. (August 2011). Journal of the American Academy of Child & Adolescent Psychiatry, 50(8), Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

61 AD/HD and Active Forgetting
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 AD/HD and Active Forgetting ADHD people appear to have more difficulty actively forgetting than the non-impaired because their prefrontal cortex is under activated when forgetting. Hence, their amygdali and hippocampus’ are not blocked and record the memories. Thus they have less control of their memories. As a result, they are more susceptible to distracting thoughts. Wickelgren, I. (2012). Trying To Forget. Scientific American Mind, 22(6), p Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

62 ASD Vs AD/HD On Response Inhibition
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 ASD Vs AD/HD On Response Inhibition A study comparing adults with AD/HD and adults with ASD found ASD adults had a slow but accurate response style, but AD/HD adults had an inaccurate and rapid response style. Johnston, K., Madden, A. K., Bramham, J. and Russell, A.J. (2011). Response Inhibition in Adults with Autism Spectrum Disorder Compared to Attention Deficit/Hyperactivity Disorder. Journal of Autism and Developmental Disorders, 41 (7), pp Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

63 Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 AD/HD and ASD 26% of children with PDD-NOS, or ASD have comorbid Combined Type AD/HD 33% of children with PDD-NOS, or ASD have Comorbid Inattentive AD/HD 59% of Children with PDD-NOS, or ASD have some type of AD/HD Goldstein, S. and Naglieri, J.A. (August, 2011). Neurocognitive and Behavioral Characteristics of children with ADHD and Autism: New Data and Strategies. The ADHD Report, 19(4), 10-12,16. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

64 AD/HD and Ventral Attention
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 AD/HD and Ventral Attention Helenius and colleagues found that adults with AD/HD have problems switching to stimulus-based reactions during tasks due to reduced activation of the ventral attention system in the temporal lobes. Helenius, P., Laasonen, M., Hokanen, L., Paetau, R., and Niemivirta, M. (March 1, 2011). Impaired engagement of the ventral attentional pathway in ADHD. Neuropsychologia,49(7), Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

65 Diagnosing Adult AD/HD With The DSM-IV, TR
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Diagnosing Adult AD/HD With The DSM-IV, TR The AD/HD diagnostic criterion in DSM-IV, TR were established from a field trial study of individuals ages 4 to 16. They do not apply to adults! Use 5 of 9 Hyperactive/Impulsive symptoms and 4 Inattentive symptoms for individuals 19 to 29 as cutoff. Use 4 of 9 for both (Hyperactive/Impulsive & Inattentive symptoms) for individuals over 29. Barkley, R.A. (2006). Attention Deficit Hyperactivity Disorder, Third Edition. New York, NY: Guilford, p Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

66 What does “Neurobiological” mean?
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved What does “Neurobiological” mean? Russell Barkley, Ph.D. (2008) said regarding Combined Type ADHD, “You cannot train out this disorder, period!” He went on to state the counselor is a “shepherd” of a disabled person. Barkley, R.A. (2008). Advances in ADHD: Theory, Diagnosis and Management. J & K Seminars, L.L.C., 1861 Wichersham Lane, Lancaster, PA 17603; ; Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

67 Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 Important Numbers 65 to 86 percent of children diagnosed with AD/HD in childhood will meet criteria for it on adulthood Boy out number girls with AD/HD, but there is a 1 to 1 correspondence male to female in adulthood-Don’t know why 3 to 4 percent worldwide prevalence of adult AD/HD. Barkely, R.A. (2012). ADHD: Cutting Edge Understanding and Management. Seminar sponsored by J&K Seminars, L.L.C., 1861 Wickersham Lane, Lancaster, PA Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

68 Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 Treatment of AD/HD “ADHD is currently understood as a neurodevelopmental syndrome with symptoms that are highly heritable and neurobiological in origin. Pharmacotherapy stands alone as the single most efficacious treatment for ADHD for individuals of all ages. Medications, psychostimulants in particular are effective in reducing the core symptoms of inattention, hyperactivity and impulsivity.” (p. 3) Ramsay, R. (2010). Nonmedication treatments for adult ADHD. Washington, DC: American Psychological Association Press, p. 3. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

69 Treatment of AD/HD Diagnosis Psychoeducation about AD/HD Medication
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 Treatment of AD/HD Diagnosis Psychoeducation about AD/HD Medication Accommodation Barkley, R. A. (1998). ADHD in Children, Adolescents,and Adults: Diagnosis, Assessment, and Treatment. New England Educational Institute, Cape Cod Symposia, August, Pittsfield, MA. Barkley, R.A. (2006). Attention-Deficit Hyperactivity Disorder. New York, NY: Guilford, p. 6 Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

70 AD/HD Response Rate to Stimulant Titration
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved AD/HD Response Rate to Stimulant Titration “If methylphenidate (sic., ritalin) is not effective or if there are side effects then the next alternative is dextroamphetamine (sic., dexedrine)…If the diagnosis has been appropriately made, the response rate is about 80% to 96%.” Mahoney, W. (2002). The Use of Stimulant Medication in the Treatment of Attention Deficit Hyperactivity Disorder. Pediatrics & Child Health, 7 (1), pp ; From website: Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

71 Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 AD/HD and Medication “When the discussion is specifically reserved to symptom relief and impairment reduction for ADHD, this series of articles adds to an impressive body of scientific literature demonstrating that medication treatment, in the case of methylphenidate, is cost efficient and may be all that is needed for good responders.” (p. 3) Goldstein, S. (December, 2004). Do Children with ADHD Benefit from Psychosocial Intervention, ADHD Report, 12 (6), 1-3. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

72 (MTA Study = Multimodal Treatment Assessment of AD/HD)
Kevin T. Blake, Ph.D., P.L.C. Your Tax Dollars at Work All Rights Reserved The Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder (MTA Study = Multimodal Treatment Assessment of AD/HD) 1999 Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

73 The MTA Study Mid-1990s 579 AD/HD, Combined Type Children
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved The MTA Study Mid-1990s 579 AD/HD, Combined Type Children Demographics matched the 1990 US Census Randomly assigned to one of four groups After assigned to group each child was thoroughly reassessed to make sure they were AD/HD, CT Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

74 The MTA Study Group 1: “Experimental Medication”
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved The MTA Study Group 1: “Experimental Medication” Three medications used Methyltphenidate (Ritalin) D Amphetamine (Dexedrene) Pemoline (Cylert)** If medication one did not work or there was a side effect, changed to the next medication and so on. Each month parent and child was seen by physician. Child checked for response to treatment and side effects. Each month questionnaires given to parents and teachers. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

75 Warning: Stimulants & AD/HD
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Warning: Stimulants & AD/HD “The FDA’s review of sudden death or cardiovascular incidents in patients taking AD/HD medications found 25 reports of death between 1999 and 2005 and 54 reports of serious cardiovascular problems. Some of these patients had pre-existing heart conditions or hypertension, the report noted.” Goodman, B. (2/23/2006). FDA Warning on AD/HD Medications “Premature”; National AD/HD Advocacy Group Urges Further Research. From Website: Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

76 Warning: Stimulants & AD/HD
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Warning: Stimulants & AD/HD According to the Center for Disease Control (CDC) about 2,500,000 children between 4 and 17 take AD/HD medications. “According to the Surgeon General, medication is effective for about 80 percent of the people who have the disorder.” (sic. AD/HD) Goodman, B. (2/23/2006). FDA Warning on AD/HD Medications “Premature”; National AD/HD Advocacy Group Urges Further Research. From Website: Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

77 Warning: Cylert & AD/HD
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Warning: Cylert & AD/HD Cylert (Pemoline) has a low abuse potential, but may cause liver toxicity. Must check liver enzymes every two weeks. It now has a PDR Black Box Warning. Prince, J., and Wilens, T. (2002). Medications Used in the Treatment of AD/HD in Women. In P.O. Quinn, and K.G. Nadeau (Eds.), Gender Issues and AD/HD. Silver Spring, MD: Advantage, pp Hallowell, E.M., and Ratey, J.J. (2005). Delivered From Distraction. New York, NY: Ballantine, pp. 251. Connor, D. (2006). Stimulants (Chapter 17), In R.A., Barkley, Ed, Attention-Deficit Hyperactivity Disorder, Third Edition. New York, NY: Guilford, p. 636. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

78 Warning: Strattera and AD/HD
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Warning: Strattera and AD/HD PDR Warning about liver problems. Two people have had liver function problems who have been placed on this medication. Surman, C. (May 12, 2005). AD/HD and Comorbidity. Paper presented at the National Attention Deficit Disorder Association Annual Conference, May 12-15, 2005, Tucson, AZ. Spencer, T.J. (2006). Antidepressant and Specific Norephinephrine Reuptake Inhibitor Treatments, Chapter 18, In R.A. Barkley, Ed., Attention-Deficit Hyperactivity Disorder. New York, NY: Guilford, p. 653. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

79 POPULATIONS World’s projected population as of 01/01/07:
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved POPULATIONS World’s projected population as of 01/01/07: 6,605,046,992 X 5 (Years) US Population as of 12/06/06: 300,351,641 X 1 (Year) From US Census Bureau World Population Clock Projections: and Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

80 “My daughter died after taking aspirin.”
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved “My daughter died after taking aspirin.” “Health experts have issued a warning that children under the age of 19 should not take aspirin because the risk of a rare but potentially fatal condition called Reye’s Syndrome.” Each year there are an estimated 7600 deaths and 76,000 hospitalizations from taking non-steroidal anti-inflammatory drugs (NSAID). What is a NSAID? Aspirin! BBC News World Edition (10/23/2002). “My Daughter Died After Taking Aspirin”. From website: From website: Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

81 The MTA Study Group 2: Behavior Modification
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved The MTA Study Group 2: Behavior Modification Parents taught how to use token economies at home and daily report cards, teachers taught how to teach AD/HD child, how to use token economies in the classroom, and daily report cards, AD/HD children were sent to special camp for AD/HD kids, parents and teachers given “800” number for consultation 24/7, continued on for 14 months! Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

82 Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved The MTA Study Group 3: “Experimental Medication Plus Behavior Modification Group” Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

83 The MTA Study Group 4: “Community Services”
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved The MTA Study Group 4: “Community Services” The parents are told their child has Combined Type AD/HD and they are encouraged to go out to their community and get what services they want for their child…This was the “Control Group.” Medication, aroma therapy, etc. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

84 Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved MTA STUDY Jensen, P.S., et al. (February, 2001). Findings From the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and Applications for Primary Care Providers. Journal of Developmental and Behavioral Pediatrics, 22 (1), pp Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

85 Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved MTA Study Medication Management Treatment Group did best. 50% decline in symptoms. Medication with Behavioral Modification Group did no better. Behavior Modification Group did better than placebo. Community Treatment only had 25% decline in symptoms. Medication helps with social interaction. NIMH Research Treatment for Attention Deficit Hyperactivity Disorder (ADHD): The Multimodal Treatment Study – Questions and Answers. From website: Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

86 Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved MTA Study “In that study (MTA Cooperative Group, 1999) psychosocial treatment alone was very poor compared to medication effects and psychosocial treatment with methylphenidate was no better than methylphenidate alone…Medication was found to reduce negative social interactions both by the treated children and by their peers toward the child with ADHD”. (p. 55) Semrud-Clickman, M. (2007). Social Competence in Children. New York, NY: Springer, p. 55. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

87 AD/HD Response Rate to Stimulant Titration
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved AD/HD Response Rate to Stimulant Titration “If methylphenidate (sic., ritalin) is not effective or if there are side effects then the next alternative is dextroamphetamine (sic., dexedrine)…If the diagnosis has been appropriately made, the response rate is about 80% to 96%.” Mahoney, W. (2002). The Use of Stimulant Medication in the Treatment of Attention Deficit Hyperactivity Disorder. Pediatrics & Child Health, 7 (1), pp ; From website: Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

88 Kevin T. Blake, Ph.D., P.L.C. MTA Study All Rights Reserved “Based on these findings, we concluded that for AD/HD symptoms, a closely monitored medication approach of the MTA was superior to behavioral treatment alone and routine community treatment that included medication. Combined treatment offered slightly greater benefits than medication management alone for AD/HD symptom reduction as well as for other domains, such as peer relations, parent-child relations and academic outcomes.” (p. 64) Combined group used 20% less medication than Medication Only group. 24-month follow-up same basic results. Jensen, P.S., Abikoff, H.B., Arnold, L.E., Epstein, J., Greehill, L.L., Hechtman, L., Hinshaw, S.P., March, J.S., Newcorn, J.H., Swanson, J.M., Vitello, B., Wells, K. and Wigal, T. ( ). A 24-Month Follow-up to the NIMH MTA Study. The New CHADD Information and Resource Guide to AD/HD. Landover, MD: CHADD, pp Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

89 Medication and Social Interaction
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Medication and Social Interaction “The medications used to treat AD/HD often have positive social effects; in fact most children feel an improvement in the way they relate to others.” (Aull, April, 2005, p. 36) Aull, E.B. (April, 2005). Social Skills Improvement with AD/HD Medication. Attention!, 12 (2), pp Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

90 Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved AD/HD and Medication “When the discussion is specifically reserved to symptom relief and impairment reduction for ADHD, this series of articles adds to an impressive body of scientific literature demonstrating that medication treatment, in the case of methylphenidate, is cost efficient and may be all that is needed for good responders.” (p. 3) Goldstein, S. (December, 2004). Do Children with ADHD Benefit from Psychosocial Intervention, ADHD Report, 12 (6), 1-3. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

91 Stimulant Medications Used to Treat AD/HD That Are Approved by the FDA
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 Stimulant Medications Used to Treat AD/HD That Are Approved by the FDA Methylphenidate (Ritalin) Dexedrine (Amphetamine) Delivery Systems Concerta/OROS Medidate/Diffucaps, microl, SODAS Methapatch/Patch Focalin/isomer Barkley, R.A. (2012). ADHD: Cutting Edge Understanding and Management. Seminar sponsored by J&K Seminars, L.L.C., 1861 Wickersham Lane, Lancaster, PA Delivery Systems Adderall XR/ 4 amphetamine salts Vyvance (lisdexamfetamine)/becomes active when combined with stomach acids Barkley, R.A. (2012). ADHD: Cutting Edge Understanding and Management. Seminar sponsored by J&K Seminars, L.L.C., 1861 Wickersham Lane, Lancaster, PA Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

92 Other Medications for AD/HD Approved by the FDA
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 Other Medications for AD/HD Approved by the FDA Atomoxetine/ Strattera-Norepinephrine reuptake inhibitor Intunive XR/ Guanfacine XR-Anti-Hypertensive Kapvay/ clonidine hydrochloride-Anti-Hypertensive Barkley, R.A. (2012). ADHD: Cutting Edge Understanding and Management. Seminar sponsored by J&K Seminars, L.L.C., 1861 Wickersham Lane, Lancaster, PA Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

93 “Typical” Medications Given Off-Label for AD/HD
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 “Typical” Medications Given Off-Label for AD/HD Meth-amphetamine-Addictive Tricyclic Anti-Depressants-don’t work as well & cardiac concerns Welbutrin/bupropoion- stimulants work better Anti-histamines/Doesn’t work very well Barkley, R.A. (2012). ADHD: Cutting Edge Understanding and Management. Seminar sponsored by J&K Seminars, L.L.C., 1861 Wickersham Lane, Lancaster, PA Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

94 Stimulants Typically Work with AD/HD, Combined Type
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 Stimulants Typically Work with AD/HD, Combined Type They improve 70 to 90 percent of clinical and normalize 50 to 60 percent of those while on a therapeutic dose. Barkley, R.A. (2012). ADHD: Cutting Edge Understanding and Management. Seminar sponsored by J&K Seminars, L.L.C., 1861 Wickersham Lane, Lancaster, PA , page 57. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

95 Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 How Stimulants Work “Our results suggest that enhancing dopamine D4 transmission in the basal ganglia and the thalamus is likely part of the mechanism of the therapeutic effects of psychostimulants on ADHD.” (Quoting David Erlig, M.D., Ph.D., SUNY) Erlij believes the therapeutic action of psychostimulants in ADHD occurs because the condition is caused by abnormalities of dopamine signaling in the brain. That is, when an individual has ADHD, the dopamine D4 receptor gene is abnormal. Nauert, R. (February 8, 2012). Rat Study Suggests How Stimulants Reduce ADHD Symptoms. PsychCentral: Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

96 Long Term Study of Stimulant Medication with AD/HD Adults
Kevin T. Blake, Ph.D., P.L.C. CHADD of Tucson Long Term Study of Stimulant Medication with AD/HD Adults Typically the longest studies of stimulant medication with adults with AD/HD last several weeks. Recently one was conducted that lasted 2 years. Prior studies of children with AD/HD indicate that only between 21-34% remain on their medication after 2 years. Recently researchers did a follow-up study of 133 adults with AD/HD who were on stimulant medication. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

97 Long Term Study of Stimulant Medication with AD/HD Adults
Kevin T. Blake, Ph.D., P.L.C. CHADD of Tucson Long Term Study of Stimulant Medication with AD/HD Adults The researchers found after 6 to 9 months 80% of the adults were still taking their medication, but after 2 years only 50% were taking their medication. 22% of those who discontinued could not come up with a reason why they did; 16.7% said they quite because of anxiety and/or depression; 15.5% said they believed the medication did not work; and 7.6% said they had negative side effects. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

98 Long Term Study of Stimulant Medication with AD/HD Adults
Kevin T. Blake, Ph.D., P.L.C. CHADD of Tucson Long Term Study of Stimulant Medication with AD/HD Adults After 2 years those who remained on the medication had a significant increase in their pulse, but not blood pressure. For those who remained on their medication they appeared to find it effective and reported minor side effects. The researchers believed the fact they had follow-up meeting with the research subjects may have raised the rate of those who remained on the medication for two years and suggested clinicians periodically follow-up with their clients to help ensure they are taking their medication. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

99 Kevin T. Blake, Ph.D., P.L.C. CHADD of Tucson References Knouse, L. (June, 2011). Predictors of Adherence to Long-Term Stimulant Treatment in Adults. The ADHD Report, 19(3), 10. Bejerot, S., Ryden, E.M., Arlinde, C.N. (2010). Two-Year Outcome of Treatment With Central Stimulant Medication in Adult Attention-Deficit/Hyperactivity Disorder: A Prospective Study. Journal of Clinical Psychiatry, 71(12), Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

100 ADULT AD/HD & TREATMENT
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved ADULT AD/HD & TREATMENT Cognitive Behavioral Therapy works with AD/HD adults because they have better developed frontal lobes than children. They still need medication, however. This means adults with AD/HD can get some good out of social skills training whereas AD/HD children typically do not. Barkley, R.A. (2006). Attention-Deficit Hyperactivity Disorder, Third Edition. New York, NY: Guilford. Ramsay, R. J. (2010). Non-Medication Treatments for Adult ADHD. Washington, DC: American Psychological Association. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

101 Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved Barkley’s 80%- 20% Rule Using Barkley’s theory of AD/HD (Combined Type) and his theory of executive functioning he concludes that AD/HD, “…has disconnected the knowing from the doing brain.” Thus, he says 80% of the effort to manage a person’s behavior with AD/HD must be done with environmental modifications (token economies, timers, etc.) The remaining 20% of the management effort goes into training of skills. Barkley, R.A. (November 12, 2010). The Nature of Executive Functioning in ADHD: Implications for Assessment and Management. Paper Presented at the 22nd Annual CHADD International Conference, Atlanta, GA. Barkley, R.A. (in press). Attention-Deficit/Hyperactivity Disorder, Executive Functioning, and Self-Regulation. In R.F. Baumeister & K.D. Vohs (Eds.), Handbook of Self-Regulation: Research , Theory and Applications, 2nd Edition. New York, NY: Guilford. Barkley, R.A. (2011). Executive Functioning in Daily Life Activities: Theory, Integration and Clinical Implications. New York, NY: Guilford. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

102 Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 AD/HD & Coaching “Students reported that ADHD coaching helped them become more self-regulated, which led to positive academic experiences and outcomes. Students described ADHD coaching as a unique service that helped them develop more productive beliefs, experience more positive feelings, and engage in more self-regulated behaviors. Conclusion: ADHD coaching helped participants enhance their self-control as they responded to the multifaceted demands of undergraduate life”. Parker, D.R., Hoffman, S.F., Sawilowsky, S., Rolands (December 15, 2011). Self-Control in Postsecondary Settings: Students’ Perceptions of ADHD College Coaching. Journal of Attention Disorders, doi: / Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

103 Possible Alternative Medicine Treatment for Working Memory Problems
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 Possible Alternative Medicine Treatment for Working Memory Problems Working Memory Training: Torkel Klingberg, M.D., Ph.D. Karolinska Institute- Stockholm, Sweden CogMed software company (RM Program) AD/HD deficient in visual spatial working memory. Gets worse with age. MAY help relieve executive functioning difficulties and reading comprehension problems in Combined Type AD/HD. More Research is needed! Klingberg, T. (February, 2006). Training Working Memory. AD/HD Report, 14 (1), pp. 6-8. Barkley, R. (February, 2006). Editorial Commentary Issues in Working Memory Training in ADHD. ADHD Report, 14 (1), pp Ingersoll, B. (October 26, 2006). Complementary Treatments for AD/HD. Paper Presented at the 18th Annual CHADD International Conference, Chicago, IL. Klingberg, T. and Andersson, M. (October 28, 2006). Computerized Training of Working Memory in Children with AD/HD. Paper presented at the 18th Annual CHADD International Conference, Chicago, IL. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

104 Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved COGMED and ADHD Recent study has shown that the use of COGMED with stimulant medication reduces working memory deficits better than medication alone. Children with ADHD went up 1 SD in working memory and results held for 6 months. Holms, J., Gathercole, S.E., Place, M., Dunning, D.L., Hilton, K.A. and Elloitt, J.G. (2009). Working memory deficits can be overcome: Impacts of training and medication on working memory in children with ADHD. Applied Cognitive Psychology, From Wiley Interscience abstract: www3.interscience.wiley.com/journal/ /abstract?CRETRY+1&SRETRY=0 Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

105 COGMED and ADHD Treatment Group:
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved COGMED and ADHD Treatment Group: Significant gains in all types of working memory, even verbal STM and WM. Subjects follow directions better, too. No significant drops in 6 months. Significant increases in math and following directions in 6 months. Holmes, J., Gathercole, S.E., and Dunning, D.L. (2009). Adaptive training leads to sustained enhancement of poor working memory in children. Developmental Science, 12, F9-F15. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

106 COGMED and ADHD Second study:
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved COGMED and ADHD Second study: Children with low working memory for their age Random assignment into two groups: treatment and sham treatment/control Treatment group showed significant improvement in verbal short-term memory and verbal working memory. No difference found on visual-spatial working memory and visual-spatial short-term memory. Holms, J., Gathercole, S.E., Place, M., Dunning, D.L., Hilton, K.A. and Elloitt, J.G. (2009). Working memory deficits can be overcome: Impacts of training and medication on working memory in children with ADHD. Applied Cognitive Psychology, From Wiley Interscience abstract: www3.interscience.wiley.com/journal/ /abstract?CRETRY+1&SRETRY=0 Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

107 COGMED www.cogmed.com Kevin T. Blake, Ph.D., P.L.C. 3/25/2017
Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

108 Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 Exercise and ADHD Ratey (2008) stated that aerobic exercise for 30 minutes a day can increase dopamine and norepinephrine (two neurotransmitters related to ADHD) for up to 90 minutes. “For most of my patients, I suggest exercise as a tool to help them manage their symptoms along with their medication.” (p. 164) Ratey, J.J. (2008). Spark: The revolutionary new science of exercise and the brain. New York, NY: Little, Brown and Company. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

109 Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 ADHD & Exercise Barkley (2008) stated if you have combined type ADHD you should take a run just before an examination instead of review your notes one more time. He recommends people with ADHD have a regular mild aerobic exercise routine, too. Barkley, R.A. (2008). Advances in ADHD: Theory, diagnosis and management. J & K Seminars, L.L.C., 1861 Wichersham Lane, Lancaster, PA 17603; ; disc 7, track 11. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

110 Excellent Book on Exercise and ADHD
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 Excellent Book on Exercise and ADHD Ratey, J.J. (2008). Spark: The Revolutionary New Science of Exercise and The Brain. New York, NY: Little, Brown. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

111 Complementary & Alternative Treatments Not Backed by Research
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 Complementary & Alternative Treatments Not Backed by Research Light Therapy Repetitive Transcranial Magnetic Stimulation Magnetic bed mattresses Vestibular and Cerebellar Exercises Massage Interactive Metronome Chiropractic treatment Vision therapy Acupuncture Mirror feedback Herbal & Homeopathic Treatments Tarantula venom Ramsay, R. (2010). Nonmedication Treatments for Adult ADHD. Washington, DC: American Psychological Association Press. Barkley, R.A. (2008). Advances in ADHD: Theory, diagnosis and management. J & K Seminars, L.L.C., 1861 Wichersham Lane, Lancaster, PA 17603; ; Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

112 Recent Review of Neurobiofeedback Research Results with AD/HD
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 Recent Review of Neurobiofeedback Research Results with AD/HD Based on the results and methodologies of published studies, this review concludes that NF for pediatric ADHD can be currently considered as “probably efficacious.” Lofthouse, N, Arnold, E., Hersch, S. Hurt, E., and DeBeus, R. (November 16, 2011). A Review of neurobiofeedback Treatment for Pediatric ADHD. Journal of Attention Disorders. doi: / Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

113 Neurobiofeedback and AD/HD
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 Neurobiofeedback and AD/HD Ramsay stated that support for neurobiofeedback is, “…tentative and not conclusive, and the percise mechanisms of change remain unclear…” (p.123). Ramsay, R. (2010). Nonmedication Treatments for Adult ADHD. Washington, DC: American Psychological Association Press. For further discussion of this hotly debated topic go to Dr. Blake’s website’s webinar extra slide page: Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

114 DSM-5? Types of ADHD: AD/HD (Combined Type)
Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved DSM-5? Types of ADHD: AD/HD (Combined Type) AD/HD, Not Otherwise Specified AD/HD + Conduct Disorder, Callous and Unemotional Specifier Sluggish Cognitive Tempo/Attention Deficit Disorder The above recently has been changed! Author (2010). ADHD and Disruptive Behavior Disorders. Washington, DC: American Psychiatric Association; Author (February 2, 2010). DSM-5: Options Being Considered for ADHD. Washington, DC: American Psychiatric Association; Barkley, R.A. (2008). Advances in ADHD: Theory, Diagnosis and Management. J & K Seminars, L.L.C., 1861 Wichersham Lane, Lancaster, PA 17603; ; Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

115 Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved DSM-5? 5. Temper Dysregulation Disorder with Dysphoria and Comorbid AD/HD Recently changed to Disruptive Mood Dysregulation Disorder Author (2010). Disruptive Mood Dysregulation Disorder. Washington, DC: American Psychiatric Association; Author (February 14-16, 2007). Externalizing Disorders of Childhood (Attention-deficit/Hyperactivity Disorder, Conduct Disorder, Oppositional-defiant Disorder, Juvenile Bipolar Disorder. Washington, DC: American Psychiatric Association; Author (2010). Justification for Temper Dysregulation Disorder with Dysphoria. Washington, DC: American Psychiatric Association; Barkley, R.A. (2008). Advances in ADHD: Theory, Diagnosis and Management. J & K Seminars, L.L.C., 1861 Wichersham Lane, Lancaster, PA 17603; ; Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

116 Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved What should be used by won’t be used as the adult symptoms of ADHD for DSM-5 “Is often easily distracted by extraneous stimuli Often makes decisions impulsively Often has difficulty stopping activities or behavior when he/she should do so Often starts a project or task without reading or listening to directions carefully Often shows poor follow-through on promises or commitments made to others Often has trouble doing things in their proper order or sequence…” Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

117 Kevin T. Blake, Ph.D., P.L.C. All Rights Reserved What should be used by won’t be used as the adult symptoms of ADHD for DSM-5 7. Often more likely to drive a motor vehicle much faster than others Often has difficulty sustaining attention in tasks or leisure activities Often has difficulty organizing tasks and activities” (p. 10) Cutoff: 6 of 9; in two settings; onset before age 16 Barkley, R.A. and Murphy, K.R. (August 2006). Identifying New Symptoms for Diagnosing ADHD in Adulthood. ADHD Report, 14 (4), 7-11. Barkley, R.A. Murphy, K.R. and Fischer, M. (2008). ADHD in Adults: What The Science Says. New York, NY: Guilford, p. 437. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

118 Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 At Last Publishing here is what the DSM-5 Committee is Planning for AD/HD AD/HD will be diagnosed according to how the person currently presents their symptoms. Hence: Combined Presentation Predominately Inattentive Presentation (Combined Type “light” mostly adults) Hyperactive Impulsive Presentation (Mostly preschoolers) Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

119 Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 At Last Publishing here is what the DSM-5 Committee is Planning for AD/HD Hence, there is only one type of AD/HD which is Combined Type AD/HD which manifests its symptoms differently as a person develops neurobiologically throughout life. There will be 22 symptoms of AD/HD instead of 18 The cutoff age for having some symptoms of AD/HD will be 12; I favor 16, but what do I know? Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

120 Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 At Last Publishing here is what the DSM-5 Committee is Planning for AD/HD They will use the same symptoms for adult AD/HD as they will for children (Question: how many 5 year olds have lousy driving records?) They will probably have the same symptom cutoffs for adults and children. Although they did at one time give every indication that this would not be the case (I don’t like this either) Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

121 How Will DSM-5 Deal with SCT?
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 How Will DSM-5 Deal with SCT? There will be a diagnosis of “Attention-Deficit/Disorder Restrictive Presentation”. Which means the person can never have more than two Hyperactive/Impulsive symptoms during their entire life, but they meet criteria for Inattentive AD/HD. I think this is better than nothing. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved

122 What is Attention-Deficit/Hyperactivity Disorder, Inattentive Restrictive & SCT?
For more information about AD/HD, Inattentive Restrictive A.K.A. Sluggish Cognitive Tempo please attend Dr. Blake’s webinar through Cross Country Education: Understanding Inattentive AD/HD: recent Updates in Evidence-Based Screening and Treatment Strategies Please go to the Upcoming Webinars and Seminars page of this website for details.

123 The Third Type of AD/HD in DSM-5
Kevin T. Blake, Ph.D., P.L.C. 3/25/2017 The Third Type of AD/HD in DSM-5 “Attention-Deficit/Hyperactivity Disorder Not Elsewhere Classified” This is the old NOS diagnosis. Those who would come under this diagnosis would be those with an “Acquired AD/HD, and or adults who have gone into remission, doe not meet clinical criteria for AD/HD, but are still experiencing significant impairment in major life activities due to their remaining troublesome symptoms. Kevin T. Blake, Ph.D., P.L.C All Rights Reserved All Rights Reserved


Download ppt "What’s New With Attention-Deficit/Hyperactivity Disorder In Adults?"

Similar presentations


Ads by Google